Screen Reader Access   

Patent Licensing Details

Technology reference number: 201811022084
First Published on: NA
Title of the technology: A pharmaceutical composition for the treatment of IL9 mediated autoimmune inflammatory diseases and uses thereof
Technology Brief: NA
Potential Application(s): Na
Advantage(s): NA
IP status: Provisional Patent application Filed
Development status: Na
Researcher(s): NA
Owner(s): THSTI
Last date to receive interest:
Image(s): NA